The investments highlight a shift toward moving sophisticated diagnostics upstream. ImageAiD utilizes Mayo Clinic-validated research paired with a handheld Doppler device to identify PAD years before physical symptoms emerge. Moonrise Medical focuses on operational efficiency, automating ultrasound assessments and Pedal Acceleration Time calculations to allow front-line clinicians to evaluate vascular health without needing specialized sonographers.
Mike Shufeldt, portfolio manager at Jetstream, emphasized that current clinical practices remain too reactive. By leveraging a leadership team with deep roots in clinical medicine and commercialization, the fund aims to capture specialized medical startups that often evade broader venture networks. The fund maintains a $5,000 minimum investment threshold, positioning these healthtech tools alongside its existing holdings in companies like SpaceX and Shield AI.
Comments (0)
No comments yet. Be the first!